Literature DB >> 9503278

Ameliorative influence of a nootropic drug on motor activity of rats after bilateral carotid artery occlusion.

A Gschanes1, V Valousková, M Windisch.   

Abstract

The effects of the peptidergic nootropic drug Cerebrolysin on spatial memory and motor activity were examined in intact and ischemic rats. Ischemic-hypoxic damage was induced by injection of Na-cyanide followed by bilateral occlusion of common carotid arteries. Immediately afterwards Cerebrolysin or saline was administered, either by continuous intraventricular (i.v.) infusion or by daily intraperitoneal (i.p.) injection. Rats were tested for spatial memory and motor activity in the Morris water maze on days 3 and 4 post-surgery. The best dose of the substance for i.p. administration was known from previous studies. Therefore we had to investigate the dose-response-relationship and tolerability of the drug after i.v. administration in intact rats. Infusion (i.v.) of a high dose of Cerebrolysin (0.57 mg/day) decreased motor activity and spatial memory of intact rats (p < 0.01 and p < 0.05, respectively) but low dose of Cerebrolysin was well tolerated in the intact animals. Ischemia led to deterioration of motor activity in control rats (p < 0.01). Cerebrolysin significantly counteracted deleterious motor changes due to ischemia up to the level of intact controls after both i.v. infusion (0.0057 mg/day) and daily i.p. drug administration (100 mg/kg bw and day) indicating an accelerating recovery after ischemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9503278     DOI: 10.1007/BF01294733

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  19 in total

1.  A multidimensional approach in testing nootropic drug effects (Cerebrolysin).

Authors:  B Kofler; C Erhart; P Erhart; G Harrer
Journal:  Arch Gerontol Geriatr       Date:  1990 Mar-Apr       Impact factor: 3.250

2.  Dose-dependent behavioural effects of two protein-free peptide derivatives on the passive avoidance reaction of rats.

Authors:  B Hutter-Paier; U Eggenreich; M Windisch
Journal:  Arzneimittelforschung       Date:  1996-03

3.  Effects of brain tissue hydrolysate on synaptic transmission in the hippocampus.

Authors:  A Baskys; J M Wojtowicz
Journal:  Pharmacol Biochem Behav       Date:  1994-12       Impact factor: 3.533

4.  A behavioral study of bilateral middle cerebral artery hemorrhagic ischemia in rats.

Authors:  J C Tucker; W F McDaniel; S R Smith
Journal:  Neuroreport       Date:  1992-08       Impact factor: 1.837

5.  Neurobehavioral deficit due to ischemic brain damage limited to half of the CA1 sector of the hippocampus.

Authors:  R N Auer; M L Jensen; I Q Whishaw
Journal:  J Neurosci       Date:  1989-05       Impact factor: 6.167

6.  Postnatal administration of two peptide solutions affects passive avoidance behaviour of young rats.

Authors:  B Paier; M Windisch; U Eggenreich
Journal:  Behav Brain Res       Date:  1992-10-31       Impact factor: 3.332

7.  [Modification of rat brain metabolism by long-term treatment with a peptide derivative].

Authors:  M Windisch; A Piswanger
Journal:  Arzneimittelforschung       Date:  1985

8.  Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study.

Authors:  L Francis-Turner; V Valousková
Journal:  Neurosci Lett       Date:  1996-01-05       Impact factor: 3.046

9.  Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT).

Authors:  E Rüther; R Ritter; M Apecechea; S Freytag; M Windisch
Journal:  Pharmacopsychiatry       Date:  1994-01       Impact factor: 5.788

10.  Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat brain.

Authors:  F Akai; S Hiruma; T Sato; N Iwamoto; M Fujimoto; M Ioku; S Hashimoto
Journal:  Histol Histopathol       Date:  1992-04       Impact factor: 2.303

View more
  4 in total

1.  Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide therapeutic window.

Authors:  E Schauer; R Wronski; J Patockova; H Moessler; E Doppler; B Hutter-Paier; M Windisch
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

2.  Spotlight on cerebrolysin in dementia.

Authors:  Greg L Plosker; Serge Gauthier
Journal:  CNS Drugs       Date:  2010-03       Impact factor: 5.749

Review 3.  Cerebrolysin: a review of its use in dementia.

Authors:  Greg L Plosker; Serge Gauthier
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease.

Authors:  Cai Zhiyou; Yan Yong; Sun Shanquan; Zhang Jun; Huang Liangguo; Yan Ling; Li Jieying
Journal:  Neurochem Res       Date:  2009-01-04       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.